Physiological carboxy-truncation of α-synuclein potentiates the prion-like formation of pathological inclusions (Q57458019)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30327435%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

title

Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30327435%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

Zachary A Sorrentino

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30327435%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Niran Vijayaraghavan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30327435%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Kimberly-Marie Gorion

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30327435%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Cara J Riffe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30327435%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Kevin H Strang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30327435%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Jason Caldwell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30327435%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Benoit I Giasson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30327435%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

language of work or name

English

0 references

publication date

16 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30327435%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biological Chemistry

29 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30327435%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

volume

293

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30327435%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

issue

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30327435%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

page(s)

18914-18932

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30327435%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

29 April 2020

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC6295729/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Effects of the modification of transfer buffer composition and the renaturation of proteins in gels on the recognition of proteins on Western blots by monoclonal antibodies

1 reference

12 December 2020

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

12 December 2020

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

1 reference

12 December 2020

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

1 reference

12 December 2020

Synthetic filaments assembled from C-terminally truncated alpha-synuclein

1 reference

12 December 2020

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease

1 reference

12 December 2020

A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease

1 reference

12 December 2020

Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid

1 reference

12 December 2020

Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation

1 reference

12 December 2020

Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy

1 reference

12 December 2020

A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly.

1 reference

12 December 2020

Stress-induced aggregation profiles of GST-alpha-synuclein fusion proteins: role of the C-terminal acidic tail of alpha-synuclein in protein thermosolubility and stability

1 reference

12 December 2020

An alternatively spliced form of rodent alpha-synuclein forms intracellular inclusions in vitro: role of the carboxy-terminus in alpha-synuclein aggregation

1 reference

12 December 2020

Distinct roles of the N-terminal-binding domain and the C-terminal-solubilizing domain of alpha-synuclein, a molecular chaperone

1 reference

12 December 2020

Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein

1 reference

12 December 2020

Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases

1 reference

12 December 2020

Limited proteolysis of NACP/alpha-synuclein

1 reference

12 December 2020

Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein

1 reference

12 December 2020

Role of alpha-synuclein carboxy-terminus on fibril formation in vitro

1 reference

12 December 2020

A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114.

1 reference

12 December 2020

Rapid self-assembly of alpha-synuclein observed by in situ atomic force microscopy

1 reference

12 December 2020

Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy

1 reference

12 December 2020

Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro

1 reference

12 December 2020

The E46K mutation in alpha-synuclein increases amyloid fibril formation.

1 reference

12 December 2020

Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein

1 reference

12 December 2020

Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations

1 reference

12 December 2020

A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease

1 reference

12 December 2020

Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein.

1 reference

12 December 2020

Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.

1 reference

12 December 2020

Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease

1 reference

12 December 2020

Selective loss of nigral dopamine neurons induced by overexpression of truncated human alpha-synuclein in mice

1 reference

12 December 2020

Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo.

1 reference

12 December 2020

Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation

1 reference

12 December 2020

Investigation of alpha-synuclein fibril structure by site-directed spin labeling

1 reference

12 December 2020

The effect of truncated human alpha-synuclein (1-120) on dopaminergic cells in a transgenic mouse model of Parkinson's disease

1 reference

12 December 2020

Sequence Determinants for Amyloid Fibrillogenesis of Human alpha-Synuclein

1 reference

12 December 2020

Role of different regions of alpha-synuclein in the assembly of fibrils.

1 reference

12 December 2020

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

1 reference

12 December 2020

Characterization of antibodies that selectively detect alpha-synuclein in pathological inclusions

1 reference

12 December 2020

The fold of alpha-synuclein fibrils

1 reference

12 December 2020

Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species

1 reference

12 December 2020

Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons

1 reference

12 December 2020

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein

1 reference

12 December 2020

A novel, high-efficiency cellular model of fibrillar alpha-synuclein inclusions and the examination of mutations that inhibit amyloid formation

1 reference

12 December 2020

Non-classical exocytosis of alpha-synuclein is sensitive to folding states and promoted under stress conditions

1 reference

12 December 2020

SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease

1 reference

12 December 2020

Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathology.

1 reference

12 December 2020

The Conformation and the Aggregation Kinetics of α-Synuclein Depend on the Proline Residues in Its C-Terminal Region

1 reference

12 December 2020

Role of matrix metalloproteinase 3-mediated alpha-synuclein cleavage in dopaminergic cell death

1 reference

12 December 2020

Residue-specific fluorescent probes of α-synuclein: detection of early events at the N- and C-termini during fibril assembly

1 reference

12 December 2020

Induction of intracellular tau aggregation is promoted by α-synuclein seeds and provides novel insights into the hyperphosphorylation of tau.

1 reference

12 December 2020

Conserved C-terminal charge exerts a profound influence on the aggregation rate of α-synuclein

1 reference

12 December 2020

E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment

1 reference

12 December 2020

N-terminal deletion does not affect α-synuclein membrane binding, self-association and toxicity in human neuroblastoma cells, unlike yeast

1 reference

12 December 2020

α-synuclein phosphorylation and truncation are normal events in the adult human brain

1 reference

12 December 2020

Critical role of truncated α-synuclein and aggregates in Parkinson's disease and incidental Lewy body disease

1 reference

12 December 2020

Direct observation of the interconversion of normal and toxic forms of α-synuclein

1 reference

12 December 2020

Role of C-terminal negative charges and tyrosine residues in fibril formation of α-synuclein.

1 reference

12 December 2020

100 years of Lewy pathology

1 reference

12 December 2020

Site-specific perturbations of alpha-synuclein fibril structure by the Parkinson's disease associated mutations A53T and E46K

1 reference

12 December 2020

Distinct α-synuclein strains differentially promote tau inclusions in neurons

1 reference

12 December 2020

Structural and functional characterization of two alpha-synuclein strains

1 reference

12 December 2020

Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein

1 reference

12 December 2020

Direct observation of heterogeneous amyloid fibril growth kinetics via two-color super-resolution microscopy

1 reference

12 December 2020

Unlike twins: an NMR comparison of two α-synuclein polymorphs featuring different toxicity

1 reference

12 December 2020

Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice

1 reference

12 December 2020

Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation

1 reference

12 December 2020

Lys-63-linked ubiquitination by E3 ubiquitin ligase Nedd4-1 facilitates endosomal sequestration of internalized α-synuclein

1 reference

12 December 2020

The H50Q mutation enhances α-synuclein aggregation, secretion, and toxicity

1 reference

12 December 2020

Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice.

1 reference

12 December 2020

Quantitative measurement of intact alpha-synuclein proteoforms from post-mortem control and Parkinson's disease brain tissue by intact protein mass spectrometry

1 reference

12 December 2020

Behavioural deficits in transgenic mice expressing human truncated (1-120 amino acid) alpha-synuclein

1 reference

12 December 2020

Lysosomal enzyme cathepsin B enhances the aggregate forming activity of exogenous α-synuclein fibrils

1 reference

12 December 2020

The role of the acidic domain of α-synuclein in amyloid fibril formation: a molecular dynamics study

1 reference

12 December 2020

Cysteine cathepsins are essential in lysosomal degradation of α-synuclein.

1 reference

12 December 2020

Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism

1 reference

12 December 2020

Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies

1 reference

12 December 2020

Haploinsufficiency of cathepsin D leads to lysosomal dysfunction and promotes cell-to-cell transmission of α-synuclein aggregates

1 reference

12 December 2020

Cellular response of human neuroblastoma cells to α-synuclein fibrils, the main constituent of Lewy bodies

1 reference

12 December 2020

Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading

1 reference

12 December 2020

ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons.

1 reference

12 December 2020

Neuroinflammation in Synucleinopathies

1 reference

12 December 2020

Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein.

1 reference

12 December 2020

Structural Effects of Two Camelid Nanobodies Directed to Distinct C-Terminal Epitopes on α-Synuclein

1 reference

12 December 2020

Proteolysis of α-synuclein fibrils in the lysosomal pathway limits induction of inclusion pathology

1 reference

12 December 2020

Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease.

1 reference

12 December 2020

Molecular and Biological Compatibility with Host Alpha-Synuclein Influences Fibril Pathogenicity

1 reference

12 December 2020

Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration.

1 reference

12 December 2020

α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies

1 reference

12 December 2020

Potential Modes of Intercellular α-Synuclein Transmission

1 reference

12 December 2020

Intrastriatal injection of α-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity

1 reference

12 December 2020

α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration.

1 reference

12 December 2020

Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's disease.

1 reference

12 December 2020

Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau.

1 reference

12 December 2020

A novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathies.

1 reference

12 December 2020

Modification of C Terminus Provides New Insights into the Mechanism of α-Synuclein Aggregation

1 reference

12 December 2020

C-Terminal Truncated α-Synuclein Fibrils Contain Strongly Twisted β-Sheets.

1 reference

12 December 2020

Comparison of the in vivo induction and transmission of α-synuclein pathology by mutant α-synuclein fibril seeds in transgenic mice

1 reference

12 December 2020

Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.

1 reference

12 December 2020

Distinct differences in prion-like seeding and aggregation between tau protein variants provide mechanistic insights into tauopathies

1 reference

12 December 2020

The genetics of Parkinson disease

1 reference

12 December 2020

Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease

1 reference

12 December 2020

The coming of age of chaperone-mediated autophagy.

1 reference

12 December 2020

Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies

1 reference

12 December 2020

Is Parkinson's disease a lysosomal disorder?

1 reference

12 December 2020

Cryo-EM structure of alpha-synuclein fibrils

1 reference

12 December 2020

Localized Induction of Wild-Type and Mutant Alpha-Synuclein Aggregation Reveals Propagation along Neuroanatomical Tracts

1 reference

12 December 2020

The effect of truncation on prion-like properties of α-synuclein

1 reference

12 December 2020

Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy

1 reference

12 December 2020

Membrane binding, internalization, and sorting of alpha-synuclein in the cell

1 reference

12 December 2020

Identifiers

DOI

10.1074/JBC.RA118.005603

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30327435%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30327435%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

PubMed publication ID

30327435

1 reference